HSTM - HealthStream, Inc.
NASDAQ
->
Healthcare
->
Health Information Services
Nashville,
United States
Type: Equity
HSTM price evolution
HSTM
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $46.13 | $52.41 | $40.33 | |
| Short term investments | $36.87 | $31.27 | $30.8 | |
| Net receivables | $31.68 | $36.2 | $44.05 | $38.45 |
| Inventory | ||||
| Total current assets | $145.65 | $139.11 | $147.39 | $130.21 |
| Long term investments | $4.05 | $4.1 | $4.13 | |
| Property, plant & equipment | $29.26 | $30.72 | $32.02 | $33.12 |
| Goodwill & intangible assets | $293.68 | $296.64 | $300.05 | |
| Total noncurrent assets | $360.44 | $364.22 | $369.73 | |
| Total investments | $40.92 | $35.37 | $34.93 | |
| Total assets | $502.83 | $499.56 | $511.61 | $499.94 |
| Current liabilities | ||||
| Accounts payable | $32.08 | $25 | $5.31 | $7.46 |
| Deferred revenue | $88.78 | $100.34 | $85.79 | |
| Short long term debt | ||||
| Total current liabilities | $110.57 | $111.88 | $126.07 | $118.36 |
| Long term debt | $18.78 | $19.48 | $20.25 | |
| Total noncurrent liabilities | $38.46 | $40.68 | $40.83 | |
| Total debt | $18.78 | $19.48 | $20.25 | |
| Total liabilities | $147.35 | $150.34 | $166.75 | $159.19 |
| Shareholders' equity | ||||
| Retained earnings | $104.94 | $100.06 | $96.75 | $92.37 |
| Other shareholder equity | -$0.88 | -$1.22 | -$1.17 | -$0.69 |
| Total shareholder equity | $349.21 | $344.85 | $340.75 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $40.33 | $46.02 | $46.91 | $36.57 |
| Short term investments | $30.8 | $7.88 | $5.04 | $9.93 |
| Net receivables | $38.45 | $42.71 | $34.92 | $46.1 |
| Inventory | ||||
| Total current assets | $130.21 | $114.38 | $106.84 | $114.72 |
| Long term investments | $4.13 | $4.52 | $7.04 | $6.84 |
| Property, plant & equipment | $33.12 | $38.24 | $43.12 | $50.3 |
| Goodwill & intangible assets | $300.05 | $311.07 | $304.12 | $305.79 |
| Total noncurrent assets | $369.73 | $383.36 | $379.91 | $385.59 |
| Total investments | $34.93 | $12.4 | $12.08 | $16.77 |
| Total assets | $499.94 | $497.74 | $486.75 | $500.31 |
| Current liabilities | ||||
| Accounts payable | $7.46 | $29.46 | $5.13 | $9.33 |
| Deferred revenue | $85.79 | $82.41 | $75.4 | $82.78 |
| Short long term debt | ||||
| Total current liabilities | $118.36 | $117.21 | $100.35 | $119.44 |
| Long term debt | $20.25 | $23.32 | $26.18 | $28.48 |
| Total noncurrent liabilities | $40.83 | $46.46 | $47.38 | $46.81 |
| Total debt | $20.25 | $23.32 | $26.18 | $28.48 |
| Total liabilities | $159.19 | $163.68 | $147.73 | $166.25 |
| Shareholders' equity | ||||
| Retained earnings | $92.37 | $80.21 | $68.12 | $62.28 |
| Other shareholder equity | -$0.69 | -$0.98 | $0.11 | $0 |
| Total shareholder equity | $340.75 | $334.06 | $339.02 | $334.06 |
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $73.09 | $71.56 | $72.76 | $70.58 |
| Cost of revenue | $24.62 | $24.01 | ||
| Gross Profit | $48.63 | $47.82 | $48.14 | $46.57 |
| Operating activities | ||||
| Research & development | $12.03 | $11.93 | ||
| Selling, general & administrative | $20.09 | $19.86 | ||
| Total operating expenses | $42.13 | $43.41 | $42.45 | $42.32 |
| Operating income | $5.69 | $4.25 | ||
| Income from continuing operations | ||||
| EBIT | $6.54 | $5.42 | ||
| Income tax expense | $1.75 | $1.13 | $1.32 | $0.83 |
| Interest expense | ||||
| Net income | ||||
| Net income | $5.72 | $4.17 | $5.23 | $4.59 |
| Income (for common shares) | $5.23 | $4.59 | ||
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $279.06 | $266.83 | $256.71 | $244.83 |
| Cost of revenue | $95.02 | $91.14 | $91.03 | $89.33 |
| Gross Profit | $184.04 | $175.68 | $165.68 | $155.49 |
| Operating activities | ||||
| Research & development | $45.54 | $44.28 | $41.66 | $32.3 |
| Selling, general & administrative | $81.41 | $81.01 | $79.15 | $77.18 |
| Total operating expenses | $168.02 | $163.23 | $157.62 | $139.68 |
| Operating income | $16.02 | $12.45 | $8.05 | $15.82 |
| Income from continuing operations | ||||
| EBIT | $18.51 | $15.59 | $7.77 | $17.82 |
| Income tax expense | $3.3 | $3.49 | $1.92 | $3.73 |
| Interest expense | ||||
| Net income | ||||
| Net income | $15.21 | $12.09 | $5.84 | $14.09 |
| Income (for common shares) | $15.21 | $12.09 | $5.84 | $14.09 |
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $5.23 | $4.59 | ||
| Operating activities | ||||
| Depreciation | $10.34 | $10.53 | ||
| Business acquisitions & disposals | ||||
| Stock-based compensation | $1.06 | $1.08 | ||
| Total cash flows from operations | $20.94 | $13.81 | ||
| Investing activities | ||||
| Capital expenditures | -$7.76 | -$6.6 | ||
| Investments | $0.64 | -$2.78 | ||
| Total cash flows from investing | -$25.9 | -$19.03 | -$7.12 | -$9.38 |
| Financing activities | ||||
| Dividends paid | -$2.55 | -$1.7 | -$0.85 | -$0.76 |
| Sale and purchase of stock | -$7.28 | |||
| Net borrowings | -$0.12 | |||
| Total cash flows from financing | -$3.48 | -$2.56 | -$1.7 | -$8.27 |
| Effect of exchange rate | $0.04 | $0 | -$0.04 | $0.05 |
| Change in cash and equivalents | $17.16 | $5.8 | $12.07 | -$3.79 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $15.21 | $12.09 | $5.84 | $14.09 |
| Operating activities | ||||
| Depreciation | $41.08 | $37.95 | $36.81 | $30.19 |
| Business acquisitions & disposals | -$6.62 | -$3.96 | -$4.71 | -$121.34 |
| Stock-based compensation | $4.15 | $3.55 | $5.3 | $2.22 |
| Total cash flows from operations | $63.97 | $51.19 | $42.38 | $35.87 |
| Investing activities | ||||
| Capital expenditures | -$28.01 | -$25.08 | -$25.35 | -$18.8 |
| Investments | -$21.97 | $0.65 | $4.33 | $29.73 |
| Total cash flows from investing | -$56.6 | -$28.39 | -$25.72 | -$110.41 |
| Financing activities | ||||
| Dividends paid | -$3.06 | -$0.02 | -$0.04 | |
| Sale and purchase of stock | -$8.93 | -$23.14 | -$5.01 | -$20.02 |
| Net borrowings | -$0.12 | |||
| Total cash flows from financing | -$13.04 | -$23.7 | -$6.21 | -$20.49 |
| Effect of exchange rate | -$0.02 | $0.02 | -$0.11 | $0.06 |
| Change in cash and equivalents | -$5.69 | -$0.88 | $10.34 | -$94.97 |
News
Fundamentals
| Market cap | $737.87M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 30.41M |
| Revenue | $287.99M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $19.71M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | 37.44 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 2.56 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $0.65 |
|---|---|
| ROA | 3.91% |
| ROE | N/A |
| Debt/Equity | 0.47 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.32 |
| Quick ratio | N/A |